tamsulosin 0.4mg
Pre-clinicalUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 22/100
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Prostatic Neoplasms, Prostatectomy
Conditions
Prostatic Neoplasms, Prostatectomy
Trial Timeline
Apr 1, 2010 → Dec 1, 2011
NCT ID
NCT01209988About tamsulosin 0.4mg
tamsulosin 0.4mg is a pre-clinical stage product being developed by Astellas Pharma for Prostatic Neoplasms, Prostatectomy. The current trial status is unknown. This product is registered under clinical trial identifier NCT01209988. Target conditions include Prostatic Neoplasms, Prostatectomy.
What happened to similar drugs?
15 of 20 similar drugs in Prostatic Neoplasms, Prostatectomy were approved
Approved (15) Terminated (0) Active (5)
Hype Score Breakdown
Clinical
3
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01209988 | Pre-clinical | UNKNOWN |
Competing Products
20 competing products in Prostatic Neoplasms, Prostatectomy